685832-50-2

Upstream product

• 685832-51-3 C₂₁H₁₉F₆NO₆S 
• 156275-96-6 triisopropylsilanethiol 

Downstream Products

• 685832-52-4 2-{6-[ethyl-(4-trifluoromethoxy-phenoxycarbonyl)-amino]-5,6,7,8-tetrahydro-naphthalen-2-ylsulfanyl}-2-methyl-propionic acid tert-butyl ester 

Relevant academic research and scientific papers

TREATING SYNDROME X WITH SUBSTITUTED TETRALINS AND INDANES

The invention features tetralin and indane compounds of Formula I, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

SUBSTITUTED TETRALINS AND INDANES AND THEIR USE

This invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

SUBSTITUTED TETRALINS AND INDANES

The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, dyslipidemia.